Find disease awareness content and relevant supporting materials
Lung and liver transplantation in patients with alpha-1 antitrypsin deficiency
Alpha-1 antitrypsin (AAT) augmentation is effective in slowing the progression of emphysema due to AAT deficiency (AATD) but cannot prevent eventual progression to end-stage lung disease and complete respiratory failure, which is the leading cause of death for individuals with severe AATD.
Comparison of Graft Outcome Between Donation After Circulatory Death and Living-Donor Kidney Transplantation
Background: Donation after cardiac death (DCD) and living-donor (LD) kidney transplantation are the main kidney transplantation types in China. But the outcome of DCD kidney transplantation compared with LD kidney transplantation remains unclear.
Impact of Rituximab Induction and Living Donation on Immunoregulation and Virus Control in Renal Transplantation
This project comprises immunological and virological analyses within a prospective clinical study of Rituximab (Rtx)-treated blood group incompatible living donor...
Alpha-1 antitrypsin deficiency is under-recognized in individuals with cirrhosis undergoing liver transplantation
Objective: Under-recognition of alpha-1 antitrypsin deficiency (AATD) is well documented in AATD-lung disease but is rarely reported in patients with liver cirrhosis requiring liver transplantation.